Fortress Biotech, Inc. Quarterly Costs and Expenses in USD from Q3 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Fortress Biotech, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2018 to Q3 2024.
Fortress Biotech, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $36.7M, a 24.3% decline year-over-year.
Fortress Biotech, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $169M, a 34.8% decline year-over-year.
Fortress Biotech, Inc. annual Costs and Expenses for 2023 was $227M, a 18.8% decline from 2022.
Fortress Biotech, Inc. annual Costs and Expenses for 2022 was $279M, a 8.54% increase from 2021.
Fortress Biotech, Inc. annual Costs and Expenses for 2021 was $257M, a 84% increase from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$169M	$36.7M	-$11.8M	-24.3%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$180M	$42.7M	-$24.8M	-36.8%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$205M	$49.6M	-$21.7M	-30.4%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$227M	$39.6M	-$31.5M	-44.3%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-28
Q3 2023	$258M	$48.5M	-$18.8M	-27.9%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-14
Q2 2023	$277M	$67.5M	-$2.32M	-3.33%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023	$279M	$71.3M	+$101K	+0.14%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	$279M	$71M	-$13M	-15.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$292M	$67.3M	-$3.75M	-5.28%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	$296M	$69.8M	+$9.11M	+15%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$287M	$71.2M	+$29.6M	+71.1%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	$257M	$84M	+$46M	+121%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$211M	$71M	+$38.5M	+118%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	$173M	$60.7M	+$25.8M	+74.2%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$147M	$41.6M	+$7.16M	+20.8%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$140M	$38.1M	-$3.46M	-8.33%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-28
Q3 2020	$143M	$32.5M	+$206K	+0.64%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020	$143M	$34.9M	+$313K	+0.91%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020	$143M	$34.4M	-$4.64M	-11.9%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q4 2019	$147M	$41.5M			Oct 1, 2019	Dec 31, 2019	10-K/A	2021-04-09
Q3 2019		$32.3M	-$1.07M	-3.19%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019		$34.5M			Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019		$39.1M			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q3 2018		$33.4M			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.